Stock Track | PHARMARON Soars 11.69% Intraday on Strong Q4 Earnings and Robust New Order Growth

Stock Track

04/01

PHARMARON's stock price surged 11.69% during intraday trading on Wednesday, marking a significant upward movement.

The sharp rise appears driven by the company's recently reported strong financial performance. Specifically, its fourth-quarter net profit attributable to owners surged by 40.76% year-on-year, while revenue for the period grew by 15.93%. Furthermore, the value of new orders signed in 2025 increased by over 14% year-on-year, accelerating from earlier in the year. Based on this momentum, the company has provided an optimistic revenue growth forecast for 2026.

Analysts have noted the acceleration in overall performance and strong customer inquiry volume, contributing to positive sentiment around the stock's future development.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1149530287"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1149530287\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1149530287?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-01 16:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149530287","market":"hk","top_or_hot":-1,"title":"Stock Track | PHARMARON Soars 11.69% Intraday on Strong Q4 Earnings and Robust New Order Growth","media":"Stock Track","content":"<p>PHARMARON's stock price surged 11.69% during intraday trading on Wednesday, marking a significant upward movement.</p><p>The sharp rise appears driven by the company's recently reported strong financial performance. Specifically, its fourth-quarter net profit attributable to owners surged by 40.76% year-on-year, while revenue for the period grew by 15.93%. Furthermore, the value of new orders signed in 2025 increased by over 14% year-on-year, accelerating from earlier in the year. Based on this momentum, the company has provided an optimistic revenue growth forecast for 2026.</p><p>Analysts have noted the acceleration in overall performance and strong customer inquiry volume, contributing to positive sentiment around the stock's future development.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | PHARMARON Soars 11.69% Intraday on Strong Q4 Earnings and Robust New Order Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | PHARMARON Soars 11.69% Intraday on Strong Q4 Earnings and Robust New Order Growth\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-04-01 16:27</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>PHARMARON's stock price surged 11.69% during intraday trading on Wednesday, marking a significant upward movement.</p><p>The sharp rise appears driven by the company's recently reported strong financial performance. Specifically, its fourth-quarter net profit attributable to owners surged by 40.76% year-on-year, while revenue for the period grew by 15.93%. Furthermore, the value of new orders signed in 2025 increased by over 14% year-on-year, accelerating from earlier in the year. Based on this momentum, the company has provided an optimistic revenue growth forecast for 2026.</p><p>Analysts have noted the acceleration in overall performance and strong customer inquiry volume, contributing to positive sentiment around the stock's future development.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龍化成","start_time":0,"source_url":"","article_id":"1149530287","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149530287","pubTimestamp":1775032044,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"PHARMARON's stock price surged 11.69% during intraday trading on Wednesday, marking a significant upward movement.The sharp rise appears driven by the company's recently reported strong financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"个股追踪|康龙化成盘中大涨11.69%，Q4盈利强劲，新订单增长强劲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"PHARMARON's stock price surged 11.69% during intraday trading on Wednesday, marking a significant upward movement.The sharp rise appears driven by the company's recently reported strong financial performance. Specifically, its fourth-quarter net profit attributable to owners surged by 40.76% year-on-year, while revenue for the period grew by 15.93%. Furthermore, the value of new orders signed in 2025 increased by over 14% year-on-year, accelerating from earlier in the year. Based on this momentum, the company has provided an optimistic revenue growth forecast for 2026.Analysts have noted the acceleration in overall performance and strong customer inquiry volume, contributing to positive sentiment around the stock's future development.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}